BIO Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (BIO) is expected to report earnings on November 3, 2026, after the market close. The consensus earnings estimate is $2.61 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.8% since its last earnings release on August 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
Sector
Healthcare
Industry
Medical Instruments/Supply